Fiorino, Gionata <br/><br/>
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).  [electronic resource] 

 -  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver  05 2019 
 - 632-639 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1878-3562 
<br/><br/><label>Standard No.: </label>10.1016/j.dld.2019.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Biosimilar Pharmaceuticals--chemical synthesis<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab<br/>Italy<br/>Randomized Controlled Trials as Topic<br/>Societies, Medical<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors